Evidence map›Paper›PMID 35838186›Full record

Trial reportAnnals of medicine2022

A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC).

Yu Luo, Hongyu Li, Wenqian Chen, Yi Gao, Tianju Ma, Zi Ye, Zhaohui Li

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Anterior chamber stability during phacoemulsification: comparing different phacoemulsification systems.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yu LuoMedical School of Chinese People's Liberation Army, Beijing, China.
Hongyu LiMedical School of Chinese People's Liberation Army, Beijing, China.
Wenqian ChenDepartment of Ophthalmology, Chinese People's Liberation Army General Hospital, Beijing, China.
Yi GaoDepartment of Ophthalmology, Chinese People's Liberation Army General Hospital, Beijing, China.
Tianju MaDepartment of Ophthalmology, Chinese People's Liberation Army General Hospital, Beijing, China.
Zi YeDepartment of Ophthalmology, Chinese People's Liberation Army General Hospital, Beijing, China.
Zhaohui LiMedical School of Chinese People's Liberation Army, Beijing, China.
Chinese General Hospital College of Nursing and Liberal Arts · PHChinese People's Liberation Army · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo figure out the efficacy, effects, safety and patient's subjective perceptions of phacoemulsification with the active-fluidics system (AFS). PATIENTS AND

methodsThis was a prospective, randomized, double-masked, controlled clinical study. Age-related cataract patients were recruited and randomly assigned to the AFS group and gravity-fluidics system (GFS) group in a ratio of 1:1 to have phacoemulsification. Participants were followed up at one day, one week, one month and three months postoperatively (Chinese Clinical Trial Registry, ChiCTR2100044409).

resultsThe overall included participants were 107 finally. The total aspiration time of the AFS group was significantly less than that of the GFS group (

conclusionAFS improves the efficiency, effects, safety and patients' subjective perceptions of phacoemulsification compared with GFS. It is worthwhile to promote its application in cataract surgery.KEY MESSAGESThe active-fluidics system automatically detects and maintains stable intraocular pressure at the set value.The active-fluidics system improves the efficiency, effects, safety and patients' subjective perceptions in phacoemulsification.

Indexed as

CataractCataract ExtractionPhacoemulsificationHumansProspective StudiesVisual Acuityactive-fluidics systemCataractgravity-fluidics systemphacoemulsificationrandomized controlled trial

Identifiers

PMID35838186
PMCPMC9310653
OpenAlexW4285585137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.